Compare stocks

medmix AG is a precision delivery device company operating primarily in the healthcare and industrial sectors. Its core business involves developing and manufacturing high-precision delivery devices used in a variety of applications, including healthcare, consumer, and industrial segments. The company offers a range of products such as drug delivery devices, dental applicators, and industrial mixing solutions. Headquartered in Switzerland, medmix has a global presence with a network that supports its diverse client base. The company focuses on leveraging its expertise in high-precision engineering to offer innovative solutions that meet specific industry needs.

AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio.